[Trimethoprim-sulfamethoxazole (TM-SMZ) combination in the treatment of brucellosis].
D000293:Adolescent; D000328:Adult; D000368:Aged; D002006:Brucellosis / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D003875:Drug Eruptions / Q000209:etiology; D004341:Drug Evaluation; D005260:Female; D005334:Fever / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D013272:Stomach Diseases / Q000139:chemically induced; D013420:Sulfamethoxazole / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors; D014295:Trimethoprim / Q000009:adverse effects / Q000627:therapeutic use*
D004338:Drug Combinations; D014295:Trimethoprim; D013420:Sulfamethoxazole
L'associazione TM-SMZ nel trattamento della brucellosi